PHIBRO ANIMAL HEALTH CORP - 8-K Filing
Phibro Animal Health announced the appointment of Daniel (Dani) Bendheim as Chief Executive Officer effective July 1, 2026. The Compensation Committee approved an employment agreement with a base salary of $850,000 and a target annual bonus of 50% of his base salary, along with 300,000 performance-based restricted stock units (RSUs) that vest based on the company's stock price average from June 26 to June 30, 2031. (Items: 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFI)
Tickers: $PAHC